hépatites virales : Accueil | Santé publique Francehépatites virales - Santé publique France est un établissement public administratif sous tutelle du ministère de la santé. Notre mission : améliorer et protéger la santé des populations.Sante Publique France - L’utilisation des flux RSS du site santepubliquefrance.fr est réservée à un usage strictement personnel, non professionnel et non collectif. Toute autre exploitation doit faire l’objet d’une autorisation.https://www.santepubliquefrance.fr/rss/themes/hepatites-virales.xmlFri, 29 Mar 2024 01:00:15 +0200fr<![CDATA[Maladies à déclaration obligatoire en Centre-Val de Loire. Bulletin de santé publique, bilan 2022.]]>Wed, 7 Feb 2024 00:00:00 +0200https://www.santepubliquefrance.fr/regions/centre-val-de-loire/documents/bulletin-regional/2024/maladies-a-declaration-obligatoire-en-centre-val-de-loire.-bulletin-de-sante-publique-bilan-2022https://www.santepubliquefrance.fr/regions/centre-val-de-loire/documents/bulletin-regional/2024/maladies-a-declaration-obligatoire-en-centre-val-de-loire.-bulletin-de-sante-publique-bilan-2022<![CDATA[Hépatites B et D]]>Tue, 19 Feb 2019 19:57:47 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-dhttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d<![CDATA[Hépatites B et D]]>Tue, 19 Feb 2019 19:57:47 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/hepatites-b-et-dhttps://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/hepatites-b-et-d<![CDATA[Hépatites B et D]]>Tue, 19 Feb 2019 19:57:47 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/hepatites-b-et-dhttps://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/hepatites-b-et-d<![CDATA[Hépatite C]]>Tue, 19 Feb 2019 19:57:52 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-chttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c<![CDATA[Impact of the COVID-19 Health Crisis on Key Populations at Higher Risk for, or Living With, HIV or Hepatitis C Virus and People Working With These Populations: Multicountry Community-Based Research Study Protocol (EPIC Program)]]>Thu, 14 Dec 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/vih-sida/documents/article/impact-of-the-covid-19-health-crisis-on-key-populations-at-higher-risk-for-or-living-with-hiv-or-hepatitis-c-virus-and-people-working-with-thesehttps://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/vih-sida/documents/article/impact-of-the-covid-19-health-crisis-on-key-populations-at-higher-risk-for-or-living-with-hiv-or-hepatitis-c-virus-and-people-working-with-these<![CDATA[Impact of the COVID-19 Health Crisis on Key Populations at Higher Risk for, or Living With, HIV or Hepatitis C Virus and People Working With These Populations: Multicountry Community-Based Research Study Protocol (EPIC Program)]]>Thu, 14 Dec 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c/documents/article/impact-of-the-covid-19-health-crisis-on-key-populations-at-higher-risk-for-or-living-with-hiv-or-hepatitis-c-virus-and-people-working-with-thesehttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c/documents/article/impact-of-the-covid-19-health-crisis-on-key-populations-at-higher-risk-for-or-living-with-hiv-or-hepatitis-c-virus-and-people-working-with-these<![CDATA[Impact of the COVID-19 Health Crisis on Key Populations at Higher Risk for, or Living With, HIV or Hepatitis C Virus and People Working With These Populations: Multicountry Community-Based Research Study Protocol (EPIC Program)]]>Thu, 14 Dec 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/article/impact-of-the-covid-19-health-crisis-on-key-populations-at-higher-risk-for-or-living-with-hiv-or-hepatitis-c-virus-and-people-working-with-thesehttps://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/article/impact-of-the-covid-19-health-crisis-on-key-populations-at-higher-risk-for-or-living-with-hiv-or-hepatitis-c-virus-and-people-working-with-these<![CDATA[Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance]]>Mon, 11 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/don-de-sang/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-frohttps://www.santepubliquefrance.fr/don-de-sang/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-fro<![CDATA[Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance]]>Mon, 11 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/vih-sida/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-frohttps://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/vih-sida/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-fro<![CDATA[Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance]]>Mon, 11 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-frohttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-fro<![CDATA[Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance]]>Mon, 11 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-frohttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/article/human-immunodeficiency-virus-hepatitis-c-virus-and-hepatitis-b-virus-incidence-in-blood-donors-from-2000-to-2020-in-france-trends-and-lessons-fro<![CDATA[Hépatites B, C et Delta : une activité de dépistage élevée et en augmentation]]>Thu, 7 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/les-actualites/2023/hepatites-b-c-et-delta-une-activite-de-depistage-elevee-et-en-augmentationhttps://www.santepubliquefrance.fr/les-actualites/2023/hepatites-b-c-et-delta-une-activite-de-depistage-elevee-et-en-augmentation<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/determinants-de-sante/vaccination/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/determinants-de-sante/vaccination/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/grippe/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/grippe/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/diphterie/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/diphterie/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/tetanos/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/tetanos/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/poliomyelite/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/poliomyelite/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/infections-a-papillomavirus/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/infections-a-papillomavirus/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/rougeole/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/rougeole/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/oreillons/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/oreillons/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/rubeole/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/rubeole/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Vaccination acceptability in the French general population and related determinants, 2000-2021]]>Tue, 5 Sep 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/tuberculose/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/tuberculose/documents/article/vaccination-acceptability-in-the-french-general-population-and-related-determinants-2000-2021<![CDATA[Bulletin de santé publique maladies à déclaration obligatoire à Mayotte. Juillet 2023.]]>Wed, 26 Jul 2023 00:00:00 +0200https://www.santepubliquefrance.fr/regions/ocean-indien/documents/bulletin-regional/2023/bulletin-de-sante-publique-maladies-a-declaration-obligatoire-a-mayotte.-juillet-2023https://www.santepubliquefrance.fr/regions/ocean-indien/documents/bulletin-regional/2023/bulletin-de-sante-publique-maladies-a-declaration-obligatoire-a-mayotte.-juillet-2023<![CDATA[Hépatites virales]]>Tue, 19 Feb 2019 19:57:43 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-viraleshttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales<![CDATA[Hépatite Delta : surveillance de l’activité de dépistage et de diagnostic]]>Tue, 25 Jul 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/articles/hepatite-delta-surveillance-de-l-activite-de-depistage-et-de-diagnostichttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/articles/hepatite-delta-surveillance-de-l-activite-de-depistage-et-de-diagnostic<![CDATA[Bulletin épidémiologique hebdomadaire, 25 juillet 2023, n°15-16 Dépistage des hépatites B, C et Delta, enjeu majeur pour atteindre l’élimination, Journée mondiale contre l’hépatite, 28 juillet 2023]]>Tue, 25 Jul 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/magazines-revues/bulletin-epidemiologique-hebdomadaire-25-juillet-2023-n-15-16-depistage-des-hepatites-b-c-et-delta-enjeu-majeur-pour-atteindre-l-elimination-jhttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/magazines-revues/bulletin-epidemiologique-hebdomadaire-25-juillet-2023-n-15-16-depistage-des-hepatites-b-c-et-delta-enjeu-majeur-pour-atteindre-l-elimination-j<![CDATA[Bulletin épidémiologique hebdomadaire, 25 juillet 2023, n°15-16 Dépistage des hépatites B, C et Delta, enjeu majeur pour atteindre l’élimination, Journée mondiale contre l’hépatite, 28 juillet 2023]]>Tue, 25 Jul 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c/documents/magazines-revues/bulletin-epidemiologique-hebdomadaire-25-juillet-2023-n-15-16-depistage-des-hepatites-b-c-et-delta-enjeu-majeur-pour-atteindre-l-elimination-jhttps://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c/documents/magazines-revues/bulletin-epidemiologique-hebdomadaire-25-juillet-2023-n-15-16-depistage-des-hepatites-b-c-et-delta-enjeu-majeur-pour-atteindre-l-elimination-j<![CDATA[Éditorial. De nouvelles recommandations relancent l’objectif d’élimination des hépatites B, C et Delta d’ici 2030]]>Tue, 25 Jul 2023 00:00:00 +0200https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/article/editorial.-de-nouvelles-recommandations-relancent-l-objectif-d-elimination-des-hepatites-b-c-et-delta-d-ici-2030https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/article/editorial.-de-nouvelles-recommandations-relancent-l-objectif-d-elimination-des-hepatites-b-c-et-delta-d-ici-2030